Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bax/Bcl-2 Cascade Is Regulated by the EGFR Pathway: Therapeutic Targeting of Non-Small Cell Lung Cancer
Manzar Alam, Shoaib Alam, Anas Shamsi, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

The role of BCL-2 family proteins in regulating apoptosis and cancer therapy
Shanna Qian, Wei Zhong, Wanting Yang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 366
Current treatments for non-small cell lung cancer
Qianqian Guo, Liwei Liu, Zelong Chen, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 64
EGFR is a potential dual molecular target for cancer and Alzheimer’s disease
Hee-Jeong Choi, Yoo Joo Jeong, Ji‐Eun Kim, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 29
Investigating regulated signaling pathways in therapeutic targeting of non-small cell lung carcinoma
Manzar Alam, Gulam Mustafa Hasan, Sayed M. Eldin, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114452-114452
Open Access | Times Cited: 22
Biochemical features and therapeutic potential of α-Mangostin: Mechanism of action, medicinal values, and health benefits
Manzar Alam, Summya Rashid, Kisa Fatima, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114710-114710
Open Access | Times Cited: 21
Mechanisms of action of the BCL-2 inhibitor venetoclax in multiple myeloma: a literature review
Qiang Cao, Xinyan Wu, Qi Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 20
Dust Fall Microplastics from a Megacity of China Inhibit Autophagy via the PI3K/Akt/mTOR Pathway
Yajing Ma, Jinjin Yu, Jian Sun, et al.
Environment & Health (2025)
Open Access
Pharmacological Inhibition of MDM2 Induces Apoptosis in p53-Mutated Triple-Negative Breast Cancer
Jasmin Linh On, Sakineh Ghaderi, Carina Rittmann, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1078-1078
Open Access
Therapeutic implications and clinical manifestations of thymoquinone
Manzar Alam, Gulam Mustafa Hasan, Md. Meraj Ansari, et al.
Phytochemistry (2022) Vol. 200, pp. 113213-113213
Closed Access | Times Cited: 30
Therapeutic Targeting of Regulated Signaling Pathways of Non-Small Cell Lung Carcinoma
Gulam Mustafa Hasan, Md. Imtaiyaz Hassan, Sukhwinder Singh Sohal, et al.
ACS Omega (2023) Vol. 8, Iss. 30, pp. 26685-26698
Open Access | Times Cited: 15
Synergism Antiproliferative Effects of Apigenin and Naringenin in NSCLC Cells
Xiongxiong Liu, Ting Zhao, Zheng Shi, et al.
Molecules (2023) Vol. 28, Iss. 13, pp. 4947-4947
Open Access | Times Cited: 14
Folic acid-functionalized PEGylated niosomes co-encapsulated cisplatin and doxoribicin exhibit enhanced anticancer efficacy
Mona Safari Sharafshadeh, Farzaneh Tafvizi, Parvin Khodarahmi, et al.
Cancer Nanotechnology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Receptor-Targeted Nanomedicine for Cancer Therapy
Arvee Prajapati, Shagun Rangra, Rashmi Patil, et al.
Receptors (2024) Vol. 3, Iss. 3, pp. 323-361
Open Access | Times Cited: 5
Integrated component identification, network pharmacology, and experimental verification revealed mechanism of Dendrobium officinale Kimura et Migo against lung cancer
Yan Zhao, Shuaitao Zhu, Yuan Li, et al.
Journal of Pharmaceutical and Biomedical Analysis (2024) Vol. 243, pp. 116077-116077
Closed Access | Times Cited: 4
Highly in vitro anti-cancer activity of melittin-loaded niosomes on non-small cell lung cancer cells
Pooyan Honari, Delavar Shahbazzadeh, Mahdi Behdani, et al.
Toxicon (2024) Vol. 241, pp. 107673-107673
Closed Access | Times Cited: 4
A novel EGFR inhibitor, HNPMI, regulates apoptosis and oncogenesis by modulating BCL‐2/BAX and p53 in colon cancer
Jeyalakshmi Kandhavelu, Kumar Subramanian, Vivash Naidoo, et al.
British Journal of Pharmacology (2023) Vol. 181, Iss. 1, pp. 107-124
Open Access | Times Cited: 12
Epigallocatechin gallate modulates ferroptosis through downregulation of tsRNA-13502 in non-small cell lung cancer
Shun Wang, Ruohuang Wang, Dingtao Hu, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Scopolin obtained from Smilax china L. against hepatocellular carcinoma by inhibiting glycolysis: A network pharmacology and experimental study
Chen Wang, Qin Zhou, Songtao Wu
Journal of Ethnopharmacology (2022) Vol. 296, pp. 115469-115469
Closed Access | Times Cited: 17
Therapeutic targeting of TANK-binding kinase signaling towards anticancer drug development: Challenges and opportunities
Manzar Alam, Md. Meraj Ansari, Saba Noor, et al.
International Journal of Biological Macromolecules (2022) Vol. 207, pp. 1022-1037
Closed Access | Times Cited: 15
Therapeutic targeting of microtubule affinity‐regulating kinase 4 in cancer and neurodegenerative diseases
Manzar Alam, Sarfraz Ahmed, Mohammad Abid, et al.
Journal of Cellular Biochemistry (2023) Vol. 124, Iss. 9, pp. 1223-1240
Open Access | Times Cited: 8
Quercetin Derivatives as Potential Therapeutic Agents: An Updated Perspective on the Treatment of Nicotine-Induced Non-Small Cell Lung Cancer
Naser A. Alsharairi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15208-15208
Open Access | Times Cited: 8
Molecular Pathogenesis, Organ Metastasis, and Targeted Therapy for Non-Small-Cell Lung Cancer
Salik Abdullah, Ratul Chakraborty, Pratiksha Somnath Kumkar, et al.
Journal of Environmental Pathology Toxicology and Oncology (2024) Vol. 43, Iss. 3, pp. 13-38
Closed Access | Times Cited: 2
Babaodan overcomes cisplatin resistance in cholangiocarcinoma via inhibiting YAP1
Jiong Li, Xiangjun Ma, Faying Xu, et al.
Pharmaceutical Biology (2024) Vol. 62, Iss. 1, pp. 314-325
Open Access | Times Cited: 2
Myrtenol ameliorates inflammatory, oxidative, apoptotic, and hyperplasic effects of urethane-induced atypical adenomatous hyperplasia in the rat lung
Sedigheh Amiresmaili, Mohammad Amin Rajizadeh, Elham Jafari, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 2
Untargeted metabolomics reveal pathways associated with neuroprotective effect of oxyresveratrol in SH-SY5Y cells
Nureesun Mahamud, Phanit Songvut, Chawanphat Muangnoi, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top